This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Moslehi R, Devesa SS, Schairer C, Fraumeni JF. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936–9.
Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T, et al. Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: a SEER database analysis (2000-2015). Radiother Oncol. 2022;173:179–87.
Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88:642–9.
Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjo LD, et al. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2021;105:914–20.
National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: B-cell lymphomas, Version 3, 2023. https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf.
Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:17–29.
Teckie S, Qi S, Chelius M, Lovie S, Hsu M, Noy A, et al. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. Ann Oncol. 2017;28:1064–9.
Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013;119:629–38.
Saul EE, Alderuccio JP, Reis IM, Zhao W, Iyer SG, Rodriguez G, et al. Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. Am J Hematol. 2023;98:148–58.
Masuda Y, Takeuchi K, Kodama T, Fujisaki T, Imaizumi Y, Otsuka E, et al. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis. Int J Clin Oncol. 2019;24:1620–8.
Desai A, Joag MG, Lekakis L, Chapman JR, Vega F, Tibshirani R, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129:324–32.
Hindso TG, Esmaeli B, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, et al. International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol. 2020;104:357–62.
Lee J, Yoon JS, Kim JS, Koom WS, Cho J, Suh CO. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol. 2019;49:664–70.
Hoskin P, Popova B, Schofield O, Brammer C, Robinson M, Brunt AM, et al. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021;22:332–40.
Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J. Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiat Oncol. 2022;17:208.
Funding
This work was supported by grants from the Beijing Hope Run Special Fund of Cancer Foundation of China [grant number LC2021A01]; the National Natural Science Foundation of China [grant number 82170181]; the Beijing Natural Science Foundation [grant number 7222027]; the National Key R&D Program of China [grant number 2022YFF1502000]; and the Fundamental Research Funds for the Central Universities [grant number 3332022028].
Author information
Authors and Affiliations
Contributions
SQ, LW, YL, LG, and XL designed the study; LG and XL analyzed the data and made the figures; SQ, LW, YL, LG, XL, and XW wrote the manuscript; SQ and LW contributed to the study coordination; All authors contributed to data collection and interpretation, and finally approved the manuscript. Part of this work was accepted for Proffered oral presentation at the European Society for Medical Oncology (ESMO) Congress 2023, Madrid, Spain, 20–24 October 2023.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Gao, LR., Li, X., Wang, X. et al. Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38, 914–917 (2024). https://doi.org/10.1038/s41375-024-02227-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-024-02227-5